Docquity Expands Digitized Patient Access Programs To Enhance Healthcare Outcomes in Thailand

November 08, 2023 01:00 PM AEDT | By Cision

Docquity Expands Digitized Patient Access Programs To Enhance Healthcare Outcomes in Thailand — Image source: Kalkine Media

Recent News

Amazon down as operating income guide falls short, offseting Q1 result...

Finfluencer Culture Drives Change in Finance Education – ASX:XRO, ASX:...

WiseTech’s Bold ASX200 Move: $3.5 Billion Acquisition Plan Stirs Inves...

Rare Earth Minerals and Market Shifts: Key Insights into ASX Mining an...

After a successful pilot in the Philippines, five DocquityCare Patient Access Programs (PAPs) have been launched in Thailand
DocquityCare PAP will support more than 100 hospitals and 250 healthcare professionals (HCPs) to improve patient care for those with cancer and other life-threatening illnesses

BANGKOK, Nov. 8, 2023 /PRNewswire/ -- Docquity, Southeast Asia's largest community of HCPs connecting two out of three doctors in the region, today announced the expansion of DocquityCare PAP, its digitized patient access program, to Thailand. Docquity has introduced five PAPs in the country, supporting over 100 enrolled hospitals and 250 authorized HCPs to improve patient care for those with cancer and other life-threatening illnesses.

DocquityCare PAP Thailand

Leveraging Docquity's strong HCP network and deep expertise in healthtech innovations, DocquityCare PAP digitizes and transforms the entire PAP process, connecting pharmaceutical partners, hospitals, HCPs, and patients seamlessly through one platform. DocquityCare PAP facilitates a centralized support service for hospitals and pharmacies to improve medicine accessibility and dispensing, doctors to easily reach patients for follow-up care, and patients to access needed medicines and better adhere to treatment protocols.

DocquityCare PAP thus addresses the current limitations of conventional PAPs, including the dependence on a limited number of stores for program execution, errors and fraud due to paper-based processes, lack of data collection on prescribed and dispensed drug quantities, and the underreporting of adverse events. Since its pilot in 2021, DocquityCare PAP has empowered more than 350 doctors from 150 hospitals in the Philippines to support over 1,000 cancer patients with more accessible medication. This has delivered more than US$ 1M in total patient savings in the Philippines.

"DocquityCare PAP's expansion into Thailand allows us to advance our patient solutions capabilities in Southeast Asia and ultimate mission to build healthier lives around the world at scale. Building on our platform's cutting-edge technology, footprint, and insights, we are partnering with leading pharmaceutical companies to revolutionize PAP systems and address barriers that have previously prevented them from serving more HCPs and patients," Christophe Meugnier, General Manager of Thailand and Vietnam, Docquity, said.

About Docquity, https://docquity.com/

Docquity is Southeast Asia's largest trusted community of verified healthcare professionals. Our vision is to connect healthcare professionals to build healthier lives around the world at scale. Docquity helps healthcare professionals learn, connect, and grow, and partners with companies to reach and educate healthcare professionals as well as provide insights into them.

Docquity has more than 400,000 HCPs on the platform and offices in India, Indonesia, the Philippines, Malaysia, Singapore, Thailand, Vietnam, and Taiwan region.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.